Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) that, based on Phase 2 trial data, produces significant appetite suppression and progressive weight loss, alongside gastrointestinal side effects that are most prominent during dose escalation
While research remains ongoing, investigators are studying how Retatrutide may affect body weight, appetite regulation, glucose metabolism, and overall metabolic health
Inoculate the single colony in 5 ml MRS broth (BD Difco) aerobically at 37 C
To begin comparing options, request an appointment
US$ 25.97
US$ 24.67
US$ 29.11
US$ 28.23
US$ 27.77
US$ 26.87
US$ 22.34
US$ 25.23
